Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T21:18:38.883Z.
Calculation as of: 2026-10-06T21:18:38.883Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3426d5a31c39f39b03255f489736213a5d3ef01d64930d1418f7917ed6abe5c1
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$996.65M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$982.46M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$981.66M
EV/FCF Ratio
N/A
TTM Avg
19.90x
3Y Avg
19.90x
5Y Avg
19.90x
Market Cap
$973.93M
EV/FCF Ratio
6.57x
TTM Avg
9.54x
3Y Avg
10.29x
5Y Avg
18.38x
Market Cap
$1.02B
EV/FCF Ratio
N/A
TTM Avg
53.87x
3Y Avg
38.43x
5Y Avg
50.64x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vor Biopharma Inc. (VOR) | $992.14M | N/A | N/A | N/A | N/A |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $996.65M | N/A | N/A | N/A | N/A |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $998.69M | N/A | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $982.46M | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $981.66M | N/A | 19.90x | 19.90x | 19.90x |
| Immatics N.V. (IMTX)vs › | $1.01B | N/A | 4.12x | 4.43x | 22.97x |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $978.09M | N/A | N/A | N/A | N/A |
| Pacira BioSciences, Inc. (PCRX)vs › | $973.93M | 6.57x | 9.54x | 10.29x | 18.38x |
| Castle Biosciences, Inc. (CSTL)vs › | $1.02B | N/A | 53.87x | 38.43x | 50.64x |
| Janux Therapeutics, Inc. (JANX)vs › | $1.02B | N/A | 521.47x | 521.47x | 521.47x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
